Fairbanks Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
F5
FFIV
|
+$2.87M |
| 2 |
UnitedHealth
UNH
|
+$372K |
| 3 |
Broadcom
AVGO
|
+$352K |
| 4 |
Mastercard
MA
|
+$336K |
| 5 |
Moody's
MCO
|
+$330K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$3.22M |
| 2 |
Church & Dwight Co
CHD
|
+$1.4M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$1.38M |
| 4 |
Equifax
EFX
|
+$942K |
| 5 |
Gilead Sciences
GILD
|
+$818K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.93% |
| 2 | Industrials | 14.01% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Communication Services | 11.3% |
| 5 | Healthcare | 9.41% |
Similar funds
Fairbanks Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fairbanks Capital Management held 59 positions worth $96.8M, down 0.31% from $97.1M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Fairbanks Capital Management withdrew a net $2.97M in Q4 2019, closing 2 positions and reducing 23 holdings. Its most notable exit was Stamps.com, Inc., an estimated $1.38M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Fairbanks Capital Management opened a new position in UnitedHealth worth $418K.
- Fairbanks Capital Management's largest Q4 2019 buy was UnitedHealth: 1,421 shares worth $418K.
- Fairbanks Capital Management added most to F5 in Q4 2019, an estimated $2.87M increase.
- Fairbanks Capital Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $3.22M.
- Fairbanks Capital Management fully exited Stamps.com, Inc. in Q4 2019, selling an estimated $1.38M.
- Fairbanks Capital Management's ten largest holdings make up 54% of its $96.8M portfolio in Q4 2019.
- Fairbanks Capital Management opened 2 new positions and closed 2 in Q4 2019.
- Fairbanks Capital Management's portfolio value fell 0.31% quarter-over-quarter to $96.8M.
Based on Fairbanks Capital Management's 13F filing for Q4 2019, filed 5 Feb 2020.